0001144204-12-063233.txt : 20121115 0001144204-12-063233.hdr.sgml : 20121115 20121115163530 ACCESSION NUMBER: 0001144204-12-063233 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121109 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20121115 DATE AS OF CHANGE: 20121115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VARIAN MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000203527 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 942359345 STATE OF INCORPORATION: DE FISCAL YEAR END: 1001 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07598 FILM NUMBER: 121209171 BUSINESS ADDRESS: STREET 1: 3100 HANSEN WAY CITY: PALO ALTO STATE: CA ZIP: 94304-1000 BUSINESS PHONE: 650-424-5834 MAIL ADDRESS: STREET 1: 3100 HANSEN WAY CITY: PALO ALTO STATE: CA ZIP: 94304-1000 FORMER COMPANY: FORMER CONFORMED NAME: VARIAN ASSOCIATES INC /DE/ DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: VARIAN DELAWARE INC DATE OF NAME CHANGE: 19761123 8-K 1 v328591_8k.htm 8-K CURRENT REPORT

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

 

Date of report (Date of earliest event reported) November 9, 2012

 

 

VARIAN MEDICAL SYSTEMS, INC.
(Exact Name of Registrant as Specified in its Charter)

 

 

 

 

Delaware 1-7598 94-2359345
(State or Other Jurisdiction
of Incorporation)
(Commission File
Number)
(IRS Employer
 Identification No.)

 

 

3100 Hansen Way, Palo Alto, CA 94304-1030
(Address of Principal Executive Offices) (Zip Code)

 

 

Registrant's telephone number, including area code (650) 493-4000

 

 

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On November 9, 2012, the Compensation and Management Development Committee (the “Compensation Committee”) of the Board of Directors of Varian Medical Systems, Inc. (the “Company”) approved new compensation arrangements for certain of the Company’s executive officers. Set forth below are the annual base salaries for fiscal year 2013 for those individuals:

 

Elisha W. Finney,
     Executive Vice President, Finance and
     Chief Financial Officer
  $573,735 
Kolleen T. Kennedy,
     Senior Vice President and
     President, Oncology Systems
  $550,066 
Robert H. Kluge,
     Senior Vice President and President, X-ray Products
  $463,316 
John W. Kuo,
     Senior Vice President, General Counsel and
     Corporate Secretary
  $417,027 

 

In addition, the Compensation Committee approved increases to the percentage of salary that these executive officers can achieve if the goals under the Company’s Management Incentive Plan are achieved. Effective for fiscal year 2013, target awards (i.e., 100% goal achievement) for the individuals listed below will be the percentage of base salary that appears opposite his or her name.

 

  Elisha W. Finney 83%  
  Kolleen T. Kennedy 83%  
  Robert H. Kluge 78%  
  John W. Kuo 68%  

 

The above executive officers will not be eligible to participate in the Company’s Employee Incentive Plan commencing in fiscal year 2013.

2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Varian Medical Systems, Inc.
     
     
  By: /s/ John W. Kuo
  Name: John W. Kuo
  Title: Senior Vice President, General Counsel and
Corporate Secretary
     
     
Dated:  November 15, 2012    

 

 

1